Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    10202165 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer Patients
Condition: Cancer of Cervix
Interventions: Drug: gemcitabine;   Drug: cisplatin;   Radiation: chemoradiation
2 Withdrawn Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer
Condition: Cervical Cancer
Interventions: Drug: Bevacizumab;   Drug: Carboplatin;   Radiation: Radiation Therapy
3 Recruiting Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical Cancer
Condition: Cervical Cancer
Interventions: Drug: Weekly cisplatin with RT;   Drug: Tri-weekly cisplatin with RT

Indicates status has not been verified in more than two years